Based on data from AiDAPT trial (Automated insulin Delivery Amongst Pregnant women with Type 1 diabetes, ISRCTN56898625), the NICE Technology Appraisal [TA943] now recommends offering HCL therapy use before and during pregnancy12. Here, INS is linked to type 1 diabetes mellitus.